Notice: Trading of vTv Therapeutics halted at 08:25 AM EST due to "News pending". vTv Therapeutics (VTVT) Insider Trading & Ownership $22.74 +7.89 (+53.13%) Closing price 04:00 PM EasternExtended Trading$24.00 +1.26 (+5.54%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends vTv Therapeutics (NASDAQ:VTVT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.34%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$17,031.60Number OfInsiders Selling(Last 3 Years)0 Get VTVT Insider Trade Alerts Want to know when executives and insiders are buying or selling vTv Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VTVT Insider Buying and Selling by Quarter Remove Ads vTv Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/28/2022John A FryDirectorBuy513$33.20$17,031.60 (Data available from 1/1/2013 forward) VTVT Insider Trading Activity - Frequently Asked Questions Who is on vTv Therapeutics's Insider Roster? The list of insiders at vTv Therapeutics includes John A Fry. Learn more on insiders at VTVT. What percentage of vTv Therapeutics stock is owned by insiders? 1.34% of vTv Therapeutics stock is owned by insiders. Learn more on VTVT's insider holdings. vTv Therapeutics Key ExecutivesMr. Paul J. Sekhri M.Sc. (Age 66)CEO, President & Chairman of the Board Compensation: $650.91kMr. Steven Tuch M.B.A. (Age 55)Executive VP & CFO Compensation: $465.25kDr. Carmen Valcarce Ph.D.Chief Scientific Officer & Executive VPMs. Elizabeth M. Keiley (Age 58)Executive VP & General Counsel Mr. Richard S. Nelson (Age 54)Executive VP of Corporate Development & Director Compensation: $201.08kDr. Thomas Strack M.D.Ph.D., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies INBX Insider Trades TVGN Insider Trades CRGX Insider Trades LRMR Insider Trades FDMT Insider Trades ACRS Insider Trades NVCT Insider Trades INMB Insider Trades PLX Insider Trades CGC Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It MattersInsider Scoop: 4 Stocks Insiders Are Buying and Selling2 Stocks Insiders Are Buying and 1 They're Selling This page (NASDAQ:VTVT) was last updated on 3/17/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding vTv Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share vTv Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VTVT Stock Alerts